Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Comparative Effectiveness of Radiofrequency or Microwave Ablation and Chemotherapy for the Treatment of Large (>5 cm) Hepatocellular Carcinoma Tumors.
Journal: Cureus
Published: April 06, 2026
Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.
Journal: The Journal of international medical research
Published: March 26, 2026
Screening for Distress and Sources of Distress in Parents With Advanced Cancer and Their Coparents.
Journal: Journal of pain and symptom management
Published: December 15, 2025
Evaluation of Prophylactic EGD versus Beta Blockade in Hepatocellular Carcinoma Patients on Anti-Angiogenic Cancer Treatments.
Journal: Journal of hepatocellular carcinoma
Published: November 07, 2025
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer.
Journal: British journal of cancer
Published: February 12, 2025
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2024
EUS-guided radiofrequency ablation for pancreatic adenocarcinoma.
Journal: Gastrointestinal endoscopy
Published: January 28, 2024
False-Positive 68 Ga-DOTATATE Uptake in a Uterine Subserosal Fibroid Mimicking Mesenteric Neuroendocrine Tumor : A Case Study.
Journal: Clinical nuclear medicine
Published: July 24, 2023
A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE).
Journal: Future oncology (London, England)
Published: March 13, 2023
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer.
Journal: British journal of cancer
Published: September 19, 2022
Last Updated: 09/26/2026